Search
Menu
Rocky Mountain Instruments - Custom Assemblies LB

Thermo Fisher Secures Phadia

Facebook X LinkedIn Email
Thermo Fisher Scientific Inc. of Waltham, Mass., has acquired Phadia of Uppsala, Sweden, a provider of blood tests for the clinical diagnosis and monitoring of allergies and autoimmune diseases. Phadia now is part of Thermo Fisher’s Specialty Diagnostics business. The company is expected to contribute $0.07 to Thermo Fisher’s 2011 full-year adjusted earnings per share, an increase of $0.01 over the original estimate. In addition, it is expected to add $190 million to the US company’s 2011 revenue results, about a 12% growth in revenue over 2010.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: November 2011
    AmericasBiophotonicsblood test monitoringblood tests for clinical diagnosisBusinessearnings per shareEPSEuropelight speedMassachusettsPhadiaSwedentesting for allergies and autoimmune diseasesThermo FisherThermo Fisher ScientificThermo Fisher Specialty Diagnostics

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.